Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 known ✓ | P22748 | 5/20 | 0.55 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.32 |
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL18804464 | 0.97 | CA4 (0.52) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL3818098 | 0.97 | CA4 (0.52) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL16150006 | 0.97 | CA4 (0.59) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Silver SCHEMBL3793385 | 0.97 | CA4 (0.52) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Potassium Ion SCHEMBL5571061 | 0.97 | CA4 (0.52) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL11350148 | 0.94 | CA4 (0.48) | CA4CASP1 | |
| Silver SCHEMBL3692335 | 0.94 | CA4 (0.48) | CA4CASP1 | |
| SCHEMBL9705608 | 0.94 | CA4 (0.55) | CA4CASP1 | |
| SCHEMBL11206186 | 0.94 | CA4 (0.48) | CA4CASP1 | |
| Potassium Ion SCHEMBL17770566 | 0.94 | CA4 (0.48) | CA4CASP1FAHD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106094-A1 | Red blood cell composition | PAYRAT JEAN-MARC (BE) | 2004-06-03 | — | — | US | claimed |
| CN-117920737-B | Cleaning and advanced oxidation remediation method for high-concentration petroleum hydrocarbon contaminated soil | 大庆石油管理局有限公司 | 2025-01-03 | — | — | CN | disclosed |
| WO-2024144482-A1 | PHARMACEUTICAL ORAL SUSPENSION COMPOSITIONS COMPRISING CHENODEOXYCHOLIC ACID (CDCA) AS ACTIVE INGREDIENT AND OTHER RELEVANT EXCIPIENTS | HUMANIS SAGLIK ANONIM SIRKETI (TR) | 2024-07-04 | — | — | WO | disclosed |
| CN-117920737-A | Cleaning and advanced oxidation remediation method for high-concentration petroleum hydrocarbon contaminated soil | 大庆石油管理局有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-115305247-A | Kit for hypersensitive extraction of hepatitis C virus RNA by paramagnetic particle method and extraction method thereof | 武汉纺织大学 | 2022-11-08 | — | — | CN | disclosed |
| CN-109248150-A | A kind of amoxicillin and clavulanate potassium preparation and preparation method thereof | 鲁南制药集团股份有限公司 | 2019-01-22 | — | — | CN | disclosed |
| CN-108525016-A | PEG hydrogel and the preparation method and application thereof based on chemical bond capable of being fast degraded | 中国科学院化学研究所 | 2018-09-14 | — | — | CN | disclosed |
| CN-107768621-A | A kind of preparation method of LiFePO4/graphene/carbon composite positive pole | 郴州博太超细石墨股份有限公司 | 2018-03-06 | — | — | CN | disclosed |
| CN-107706379-A | A kind of preparation method of phosphoric acid vanadium lithium/graphene/carbon composite positive pole | 郴州博太超细石墨股份有限公司 | 2018-02-16 | — | — | CN | disclosed |
| CN-107706380-A | A kind of method that phosphoric acid vanadium lithium/grapheme composite positive electrode material is prepared in Metal Substrate | 郴州博太超细石墨股份有限公司 | 2018-02-16 | — | — | CN | disclosed |
| CN-1857222-A | Submicron docetaxel emulsion for intravenous injection and its preparing process | CHINA MEDICINE RES DEV CT CO L (CN) | 2006-11-08 | — | — | CN | disclosed |
| US-20060153804-A1 | Nucleic acid coated particles | POWDERJECT RESEARCH LIMITED | 2006-07-13 | — | — | US | disclosed |
| CN-1694721-A | Nucleic acid coated particles | POWDERJECT RES LTD (GB) | 2005-11-09 | — | — | CN | disclosed |
| US-6046107-A | FORMING COPPER OR ALLOY INTERCONNECT IN HIGH ASPECT RATIO HOLE IN SEMICONDUCTOR CHIP SUBSTRATE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2000-04-04 | — | — | US | disclosed |
| EP-0345660-B1 | STABILIZED FGF COMPOSITION AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1992-08-26 | — | — | EP | disclosed |
| EP-0345660-A1 | Stabilized FGF composition and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1989-12-13 | — | — | EP | disclosed |
| EP-0094250-B1 | Process for preparing granules containing silicone-based anti-foam | UNILEVER PLC (GB) | 1986-07-30 | — | — | EP | disclosed |
| US-4335128-A | Process for the treatment of patients suffering from drepanocytosis | OMNIUM FINANCIER AQUITAINE POUR L'HYGIENE ET LA SANTE (SANOLI) (FR) | 1982-06-15 | — | — | US | disclosed |
| US-4210649-A | Process for the treatment of patients suffering from drepanocytosis | Centre d'Etude pour l'Industrie Pharmaceutique (FR) | 1980-07-01 | — | — | US | disclosed |
| US-3932316-A | PHOSPHATE-FREE | THE PROCTER & GAMBLE COMPANY (US) | 1976-01-13 | — | — | US | disclosed |